1
|
Ameliorating Effect on Glycolipid Metabolism of Spirulina Functional Formulation Combination from Traditional Chinese Medicine. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2022; 2022:3910116. [PMID: 35873798 PMCID: PMC9300286 DOI: 10.1155/2022/3910116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Accepted: 06/16/2022] [Indexed: 12/27/2022]
Abstract
Insulin resistance is the major factor involved in the pathogenesis of type 2 diabetes. Although the oral drug metformin (MH) is widely used to reduce hyperglycemia, it is associated with adverse effects. Therefore, there is an urgent need to search for safe and natural foods that do not cause adverse effects as alternatives to commercial drugs. In this study, the active substances from Spirulina platensis, Grifola frondosa, Panax ginseng, and chromium-rich yeast were used to obtain Spirulina functional formulations (SFFs), and its therapeutic effects on mice with glycolipid metabolism disorder (GLD) were investigated. Results showed that SFFs not only improved glycolipid metabolism and reduced inflammation in mice with GLD but also showed good regenerative effects on the liver, jejunum, and cecum tissues. Moreover, SFFs could inhibit the growth of harmful microbes in the intestine and promote the proliferation of beneficial bacteria, thereby promoting the production of short-chain fatty acids and further regulating GLD. Additionally, SFFs significantly increased the expression of INS, INSR, IRS-1, PI3K, AKT-1, and GLUT-4 genes and significantly decreased that of GSK-3β in the INS/PI3K/GLUT-4 signaling pathway. Therefore, the findings of this study suggest that SFFs can be further developed as a new class of therapeutic agents against GLD.
Collapse
|
2
|
Han P, Huang Y, Hylands PJ, Legido-Quigley C. Assessment ofPolygonum capitatumBuch.-Ham. ex D.Don by metabolomics based on gas chromatography with mass spectrometry. J Sep Sci 2016; 39:1979-86. [DOI: 10.1002/jssc.201501331] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Revised: 02/03/2016] [Accepted: 03/04/2016] [Indexed: 11/12/2022]
Affiliation(s)
- Pei Han
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine; King's College London; London UK
| | - Yong Huang
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine; King's College London; London UK
- Provincial Key Laboratory of Pharmaceutics in Guizhou Province, School of Pharmacy; Guiyang Medical University; Guiyang China
| | - Peter J. Hylands
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine; King's College London; London UK
| | - Cristina Legido-Quigley
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine; King's College London; London UK
| |
Collapse
|
3
|
Rabanes HR, Guidote AM, Quirino JP. Capillary electrophoresis of natural products: Highlights of the last five years (2006-2010). Electrophoresis 2011; 33:180-95. [DOI: 10.1002/elps.201100223] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2011] [Revised: 09/22/2011] [Accepted: 09/22/2011] [Indexed: 12/14/2022]
|
4
|
Ganoderma species discrimination by dual-mode chromatographic fingerprinting: A study on stationary phase effects in hydrophilic interaction chromatography and reduction of sample misclassification rate by additional use of reversed-phase chromatography. J Chromatogr A 2010; 1217:1255-65. [DOI: 10.1016/j.chroma.2009.12.024] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2009] [Revised: 11/30/2009] [Accepted: 12/07/2009] [Indexed: 12/17/2022]
|